Evaluation of Response to Preoperative Chemotherapy Versus Surgery Alone in Gastroesophageal Cancer: Tumor Resectability, Pathologic Results and Post-Operative Complications |
Marandi, Aref Kashefi
(Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences)
Shojaiefard, Abolfazl (Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences) Soroush, Ahmadreza (Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences) Abdegah, Ali Ghorbani (Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences) Jafari, Mehdi (Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences) Khodadost, Mahmoud (Gastroenterology and Liver Research Center, Baqiyatallah University of Medical Sciences) Mahmoudzade, Hossein (Department of Surgery, Shariati Hospital, Tehran University of Medical Sciences) |
1 | Dikken JL, van de Velde CJ, Coit DG, et al (2012). Treatment of resectable gastric cancer. Therap Adv Gastroenterol, 5, 49-69. DOI |
2 | Flamant Y CJ, Huguier M, Quandalle P, et al (1999). Chimiotherapie adjuvante apres resection des adenocarcinomes gastriques: etude prospective controlee de l'effet de l'association 5FU, acide folinique et cisplatine. Gastroenterol Clin Biol, 21, 16. |
3 | Gebski V, Burmeister B, Smithers BM, et al (2007). Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol, 8, 226-34. DOI |
4 | Information on the Dutch CRITICS trial [Online]. Available: http://clinicaltrials.gov/ct2/show/NCT00407186 [Accessed 14 December 2010]. |
5 | Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. DOI |
6 | Kelsen DP, Ginsberg R, Pajak TF, et al (1998). Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer. N Engl J Med, 339, 1979-84. DOI |
7 | Law S, Fok M, Chow S, et al (1997). Preoperative chemotherapy versus surgical therapy alone for squamous cell carcinoma of the esophagus: a prospective randomized trial. J Thorac Cardiovasc Surg, 114, 210-7. DOI |
8 | Lee DJ, Sohn TS, Lim DH, et al (2012). Phase I study of neoadjuvant chemoradiotherapy with S-1 and oxaliplatin in patients with locally advanced gastric cancer. Cancer Chemother Pharmacol, 69, 1333-38. DOI |
9 | Ott K, Lordick F, Blank S, et al (2011). Gastric cancer: surgery in 2011. Langenbecks Arch Surg, 396, 743-58. DOI |
10 | Pera M, Gallego R, Montagut C, et al (2012). Phase II trial of preoperative chemoradiotherapy with oxaliplatin, cisplatin, and 5-FU in locally advanced esophageal and gastric cancer. Ann Oncol, 23, 664-70. DOI |
11 | Sadighi S, Raafat J, Mohagheghi M, et al (2005). Gastric carcinoma: 5 year experience of a single institute. Asian Pac J Cancer Prev, 6, 195-6. |
12 | Shigeoka H, Imamoto H, Nishimura Y, et al (2010). Complete response to preoperative chemoradiotherapy in highly advanced gastric adenocarcinoma. World J Gastrointest Oncol, 2, 282-6. DOI |
13 | Urba SG, Orringer MB, Turrisi A, et al (2001). Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma. J Clin Oncol, 19, 305-13. DOI |
14 | Urschel JD, Vasan H (2003). A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer. Am J Surg, 185, 538-43. DOI |
15 | Valenti V, Hernandez-Lizoain JL, Beorlegui MC, et al (2011). Morbidity, mortality, and pathological response in patients with gastric cancer preoperatively treated with chemotherapy or chemoradiotherapy. J Surg Oncol, 104, 124-9. DOI |
16 | Weber WA, Ott K, Becker K, et al (2001). Prediction of response to preoperative chemotherapy in adenocarcinomas of the esophagogastric junction by metabolic imaging. J Clin Oncol, 19, 3058-65. DOI |
17 | Working MRCOC (2002). Surgical resection with or without preoperative chemotherapy in oesophageal cancer: a randomised controlled trial. Lancet, 359, 1727-33. DOI |
18 | Ychou M, Boige V, Pignon J-P, et al (2011). Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial. J Clin Oncol, 29, 1715-21. DOI |
19 | Allum WH, Stenning SP, Bancewicz J, et al (2009). Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer. J Clin Oncol, 27, 5062-67. DOI |
20 | Ajani JA, Mansfield PF, Crane CH, et al (2005). Paclitaxel-based chemoradiotherapy in localized gastric carcinoma: degree of pathologic response and not clinical parameters dictated patient outcome. J Clin Oncol, 23, 1237-44. DOI |
21 | Ando N, Iizuka T, Ide H, et al (2003). Surgery plus chemotherapy compared with surgery alone for localized squamous cell carcinoma of the thoracic esophagus: a Japan Clinical Oncology Group Study-JCOG9204. J Clin Oncol, 21, 4592-96. DOI |
22 | Archie V, Kauh J, Jones DV, et al (2006). Gastric cancer: standards for the 21st century. Crit Rev Oncol Hematol, 57, 123-31. DOI |
23 | Berger AC, Farma J, Scott WJ, et al (2005). Complete response to neoadjuvant chemoradiotherapy in esophageal carcinoma is associated with significantly improved survival. J Clin Oncol, 23, 4330-37. DOI |
24 | Cunningham D, Allum WH, Stenning SP, et al (2006). Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med, 355, 11-20. DOI |
![]() |